Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma

References

• RastelliFBiancanelliSFalzettaATriple-negative breast cancer: current state of the artTumori201096687588821388048
   PubMed Web of Science ®Google Scholar
• Top 10 clinical trial failures of 2012 [webpage on the Internet]Genetic Engineering and Biotechnology News2013 Available from: http://genengnews.com/insight-and-intelligence/top-10-clinical-trial-failures-of-2012/77899765/Accessed February 3, 2013
   Google Scholar
• GilmourAMAbdulkhalekSChengTSA novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancerCell Signal201325122587260323993964
   PubMed Web of Science ®Google Scholar
• JayanthPAmithSRGeeKSzewczukMRNeu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signalingCell Signal20102281193120520347965
   PubMed Web of Science ®Google Scholar
• AlghamdiFGuoMAbdulkhalekSCrawfordNAmithSRSzewczukMRA novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetesCell Signal20142661355136824583283
   PubMed Web of Science ®Google Scholar
• AbdulkhalekSAmithSRFranchukSLNeu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signalingJ Biol Chem201128642365323654921873432
   PubMed Web of Science ®Google Scholar
• AbdulkhalekSGuoMAmithSRJayanthPSzewczukMRG-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of TOLL-like receptors and cellular signalingCell Signal201224112035204222759791
   PubMed Web of Science ®Google Scholar
• AmithSRJayanthPFinlayTDetection of Neu1 sialidase activity in regulating Toll-like receptor activationJ Vis Exp201043
   PubMedGoogle Scholar
• AmithSRJayanthPFranchukSNeu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signalingCell Signal201022231432419796680
   PubMed Web of Science ®Google Scholar
• AmithSRJayanthPFranchukSDependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidaseGlycoconj J20092691197121219430901
   PubMed Web of Science ®Google Scholar
• AbdulkhalekSHrynykMSzewczukMRA novel G-protein-coupled receptor-signaling platform and its targeted translation in human diseaseRes Reports in Biochemistry201331730
   Google Scholar
• O’SheaLKAbdulkhalekSAllisonSNeufeldRJSzewczukMRTherapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistanceOnco Targets Ther2014711713424470763
   PubMed Web of Science ®Google Scholar
• AbdulkhalekSGeenODBrodhagenLTranscriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinomaClin Transl Med2014328
   Google Scholar
• LehmannBDBauerJAChenXIdentification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJ Clin Invest201112172750276721633166
   PubMed Web of Science ®Google Scholar
• MazurierFFontanellasASalesseSA novel immunodeficient mouse model – RAG2 x common cytokine receptor gamma chain double mutants – requiring exogenous cytokine administration for human hematopoietic stem cell engraftmentJ Interferon Cytokine Res199919553354110386866
   PubMed Web of Science ®Google Scholar
• TanASBerridgeMVSuperoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agentsJ Immunol Methods20002381–2596810758236
   PubMed Web of Science ®Google Scholar
• CoxGJonesJLO’ByrneKJMatrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancerClin Cancer Res2000662349235510873086
   PubMed Web of Science ®Google Scholar
• SwinsonDECoxGO’ByrneKJCoexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancerBr J Cancer20049171301130715365565
   PubMed Web of Science ®Google Scholar
• WoronowiczAAmithSRDe VusserKDependence of neurotrophic factor activation of Trk tyrosine kinase receptors on cellular sialidaseGlycobiology2007171102416971381
   PubMed Web of Science ®Google Scholar
• SubikKLeeJFBaxterLThe expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell linesBreast Cancer (Auckl)20104354120697531
   PubMedGoogle Scholar
• MasudaHZhangDBartholomeuszCDoiharaHHortobagyiGNUenoNTRole of epidermal growth factor receptor in breast cancerBreast Cancer Res Treat2012136233134523073759
   PubMed Web of Science ®Google Scholar
• MeyerASMillerMAGertlerFBLauffenburgerDAThe receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cellsSci Signal20136287ra6623921085
   PubMed Web of Science ®Google Scholar
• MartinHLSmithLTomlinsonDCMultidrug-resistant breast cancer: current perspectivesBreast Cancer (Dove Med Press)2014611324648765
   PubMedGoogle Scholar
• RobertsJGChareMJForttRWLeachKGBaumMTumour histology and spleen size in women with breast cancerClin Oncol19806133387371235
   PubMed Web of Science ®Google Scholar
• RobertsJGChareMJLeachKGBaumMSpleen size in women with breast cancerClin Oncol197954317323519916
   PubMed Web of Science ®Google Scholar
• RobertsJGWisbeyMLeachKGBaumMProceedings: Spleen size in patients with breast cancerBr J Cancer19753122621164480
   PubMed Web of Science ®Google Scholar
• RobertsJGManderAMForttRWLeachKGBlighASBaumMProceedings: The relationship between spleen size, clinical staging and histological features in breast cancerBr J Surg19756221591601115904
   PubMed Web of Science ®Google Scholar
• EngerSMGreifJMPolikoffJPressMBody weight correlates with mortality in early-stage breast cancerArch Surg20041399954958 discussion 958–96015381612
   PubMedGoogle Scholar
• MehtaRSDose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradoxJ Clin Oncol2008261932863288 author reply 328818591566
   PubMed Web of Science ®Google Scholar
• LiedtkeCMazouniCHessKRResponse to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancerJ Clin Oncol20082681275128118250347
   PubMed Web of Science ®Google Scholar
• GutierrezMCDetreSJohnstonSMolecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinaseJ Clin Oncol200523112469247615753463
   PubMed Web of Science ®Google Scholar
• ShouJMassarwehSOsborneCKMechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancerJ Natl Cancer Inst2004961292693515199112
   PubMedGoogle Scholar
• YanoSWangWLiQHepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutationsCancer Res200868229479948719010923
   PubMed Web of Science ®Google Scholar
• YamadaTTakeuchiSKitaKHepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancerJ Thorac Oncol20127227228022089117
   PubMed Web of Science ®Google Scholar
• BamiasABamiaCZagouriFImproved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agentsOncology201384315816523296063
   PubMed Web of Science ®Google Scholar
• KellyMGMorGHusbandAPhase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancersInt J Gynecol Cancer201121463363921412168
   PubMed Web of Science ®Google Scholar
• FruscellaEGalloDFerrandinaGD’AgostinoGScambiaGGemcitabine: current role and future options in the treatment of ovarian cancerCrit Rev Oncol Hematol2003481818814585485
   PubMed Web of Science ®Google Scholar
• TamuraMSarayaTFujiwaraMHigh-resolution computed tomography findings for patients with drug-induced pulmonary toxicity, with special reference to hypersensitivity pneumonitis-like patterns in gemcitabine-induced casesOncologist201318445445923404815
   PubMed Web of Science ®Google Scholar
• KimMYKangSYLeeSYHypersensitivity reactions to oxaliplatin: clinical features and risk factors in KoreansAsian Pac J Cancer Prev20121341209121522799307
   PubMed Web of Science ®Google Scholar
• JinHYuYZhangTSnail is critical for tumor growth and metastasis of ovarian carcinomaInt J Cancer201012692102211119795442
   PubMed Web of Science ®Google Scholar
• CômeCArnouxVBibeauFSavagnerPRoles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progressionJ Mammary Gland Biol Neoplasia20049218319315300012
   PubMed Web of Science ®Google Scholar
• De CraeneBvan RoyFBerxGUnraveling signalling cascades for the Snail family of transcription factorsCell Signal200517553554715683729
   PubMed Web of Science ®Google Scholar
• MikamiSKatsubeKOyaMExpression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosisLab Invest201191101443145821808237
   PubMed Web of Science ®Google Scholar
• JordàMOlmedaDVinyalsAUpregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factorJ Cell Sci2005118Pt 153371338516079281
   PubMed Web of Science ®Google Scholar